Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04226417 Completed - Chronic Stroke Clinical Trials

Effect of Home Based Transcranial Direct Current Stimulation (tDCS) With Exercise on Upper and Lower Limb Motor Functions in Chronic Stroke

Start date: October 4, 2019
Phase: N/A
Study type: Interventional

The aim of the present study is to investigate the effect of home based dual tDCS combined with exercise on upper and lower limb motor functions in chronic ischemic stroke patients.

NCT ID: NCT04225468 Completed - Opioid Use Clinical Trials

Safe Options for ACL Recovery

SOAR
Start date: February 12, 2020
Phase: N/A
Study type: Interventional

The purpose of the proposed work is to test a brief opioid exposure reduction program (ACL-OERP) designed to improve health literacy about opioid use following surgeries. This intervention is specifically designed to be used with patients (or for patients under 18, the patient and caregiver) undergoing Anterior Cruciate Ligament (ACL) reconstruction, a painful surgery that is often followed by at least 7 days of opioid medication.

NCT ID: NCT04225377 Completed - Clinical trials for Physical Therapy Technology Integrated Into Physical Education Curriculum

Physical Therapy Combined With Adapted Education on Physical Fitness in College Students With Physical Disabilities

Start date: December 12, 2019
Phase:
Study type: Observational

Purpose: To integrate therapeutic exercise and techniques of physical therapy into adapted physical education courses to improve the limitations and obstacles of the physical body, and health-related physical fitness training and physical therapy into adapted physical education courses to improve the limitations and obstacles of the physical body and to improve the physical fitness performance of the students with physical and mental disabilities. Expected results: Adapting to physical education curriculum supplemented by physical therapy techniques can effectively improve the degree of physical and mental impairment, the effect of add-on fitness training, and make the physical fitness performance of students with physical and mental disabilities more progressive.

NCT ID: NCT04225364 Completed - Clinical trials for Esophageal Squamous Cell Carcinoma

Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma

Start date: January 17, 2020
Phase: Phase 2
Study type: Interventional

This study aims to evaluate the efficacy of Camrelizumab plus concurrent chemotherapy as neoadjuvant approach for patients with opearble esophageal squamous cell carcinoma. In addition, potential clinical utility of ctDNA in monitoring tumor burden and dynamics of tumor clonality during neoadjuvant immunotherapy will be assessed as well. At the same time, CD8 and PD-L1 will also be used as monitoring indicators.

NCT ID: NCT04224831 Completed - Clinical trials for Central Serous Chorioretinopathy

Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma

CSCR
Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Purpose: To investigate the efficacy of combined use of retinal repetitive electromagnetic stimulation and subtenon autologous platelet-rich plasma in the treatment of recalcitrant or unresponsive chronic central serous chorioretinopathy.

NCT ID: NCT04224571 Completed - Clinical trials for Acute Lymphoblastic Leukemia, in Relapse

CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Start date: September 14, 2018
Phase: Phase 2
Study type: Interventional

Relapsed acute lymphoblastic leukaemia (ALL) has a poorer outcome than newly diagnosed ALL patients with only about 40% overall survival after re-treatment. The study CCCG Relapsed ALL 2017 study will adopt the UK R3 study stratification and treatment backbone with two new agents added. There will be a 4-week induction, followed by two consolidation courses. High-risk patients will receive allogeneic stem cell transplant. While intermediate and standard risk groups will continue maintenance treatment for another 2 years or one year. New agents will be added aiming at improving survival outcome. 1. Study of adding anti-CD20 antibody (rituximab) with chemotherapy: CD20 is found to be expressed in 40-50% of B-lineage ALL, and rituximab has been studied in adult ALL with superior survival (75% vs 47%,). There is little experience of using rituximab in pediatric ALL thus a CCCG Relapsed ALL 2017 Study will perform the study assessing the remission rate and MRD response of CD20+ ALL treated with rituximab. Six doses of rituximab and will be monitored the week 5 MRD and relapse rate as study outcome. (This arm was terminated in October 2020 after interim analysis showing lack of efficacy) 2. Adding bortezomid during the induction: The very early or early bone marrow relapse has low remission rate. Previous case studies showed that Bortezomib, a proteasome inhibitor, may achieve remission in refractory ALL, 80% remission in B-ALL with combination of chemotherapy and bortezomib. Thus adding bortezomib, may improve the remission rate, thus bridging to allogeneic stem cell transplant. Adding bortezomib in the relapsed chemotherapy protocol may increase the toxicity and even treatment related mortality. In this protocol, we suggested to add during the induction therapy.

NCT ID: NCT04224376 Completed - Clinical trials for Anterior Cruciate Ligament Rupture

Improving Maximal Strength in the Initial Postoperative Phase After Anterior Cruciate Ligament Reconstruction Surgery: Randomized Controlled Trial of an App-Based Serious Gaming Approac

Start date: April 1, 2016
Phase: N/A
Study type: Interventional

The investigators designed a prospective randomized trial to evaluate whether an app based active muscle training program (GenuSport) can improve the postoperative strength by starting rehabilitation immediately after primary anterior cruciate ligament (ACL) reconstruction surgery as already shown for patients who underwent total knee arthroplasty. To the investigators knowledge this is the first study analyzing immediate postoperative serious gaming based training with the GenuSport device based on strength improvement.

NCT ID: NCT04224285 Completed - Clinical trials for Sleep Initiation and Maintenance Disorders

Operational Trial of Dayzz App

Start date: August 12, 2020
Phase: N/A
Study type: Interventional

Sleep deficiency is a hidden cost of our 24-7 society, with 70% of Americans admitting that they routinely obtain insufficient sleep, 30% of US workers report sleeping less than 6 hours per night, and it is estimated that 50-70 million individuals have a sleep disorder. Undiagnosed and untreated sleep disorders are associated with poor health outcomes for the individual and generate substantial costs for the employer. Diminished alertness resulting from sleep deficiency or undiagnosed and untreated sleep disorders contributes to absenteeism, presenteeism (diminished work performance at work), health care expenditure, occupational injuries, workplace accidents, and commute-related motor vehicle crashes; all of which result in substantial direct and indirect costs. The investigators have shown that adverse impacts on employees and employers can be mitigated through a sleep health education and sleep disorder screening program which have been implemented in a variety of industries. Further, smartphone apps are becoming popular. Dayzz has created a personalized sleep training app that evaluates sleep issues and offers a holistic sleep improvement solution. It is unique in that the sleep app uses evidence-based, big-data-based algorithms to provide personalized sleep training plans. The sleep solutions are tailored to the individual user and leverages unique motivational strategies and continuous supportive messaging. The investigators hypothesize that the Dayzz app, offering a personalized, scientifically based sleep training plan, might further promote improved health, safety and well-being. This clinical trial will implement the sleep health education and sleep disorders screening program in combination with the Dayzz app.

NCT ID: NCT04223986 Completed - Clinical trials for Acute Coronary Syndrome

Prehospital Risk Stratification in Acute Coronary Syndromes

Pre-ACS
Start date: November 30, 2017
Phase: N/A
Study type: Interventional

A feasibility study of prehospital echocardiographic examination and point-of-care troponin analysis, conducted by paramedics, in patients with suspected acute coronary syndrome. Echocardiographic images are sent together with information of TnT values and ECG signs to there cardiologist on call, deciding for immediate Cath lab (PCI) evaluation or local hospital evaluation.

NCT ID: NCT04223908 Completed - Clinical trials for Familial Chylomicronemia Syndrome

InFocus France Epidemiological Study of Health Burden in Major Hypertriglyceridemia

InFocus
Start date: September 19, 2018
Phase:
Study type: Observational

FCS and MCS patients recruited from 7 academic reference centers were invited to answer a paper or a web questionnaire. Questions encompassed demographics, physical, cognitive and mental symptoms, health care circuit, past and current disease management, satisfaction regarding healthcare providers and impact on daily life.